medigraphic.com
ISSN 1025-0298 (Electronic)
ISSN 1025-028X (Print)

2012, Number 2

Next >>

VacciMonitor 2012; 21 (2)

In vitro study of protein release from AFCo1 and implications in mucosal immunisation

Acevedo R, Romeu B, Zayas C, González E, Lastre M, del Campo J, Mullen A, Ferro VA, Pérez O

Language: English
References: 17
Page: 1-5
PDF size: 115.89 Kb.


ABSTRACT

Adjuvant Finlay Cochleate 1 (AFCo1) is a Proteoliposome-derived cochleate obtained from Neisseria meningitidis serogroup B. Transformation of proteoliposomes into AFCo1 potentiates the immune response on Neisseria antigens when it is administered by intranasal or intragastric (i.g) routes. However, the i.n route has been demonstrated to be more effective. The aim of this work is to evaluate in vitro the protein release from AFCo1, in simulated gastric fluid (SGF) or simulated nasal fluid (SNF) using a microdissolution test and to provide support for the results found when AFCo1 was administered by i.g or i.n routes in BALB/c mice. Results showed that dilution of AFCo1 in simulated gastric fluid affects the delivery of Neisseria protein antigens because they were released from cochleate structures faster than when simulated nasal fluid was used. In conclusion, conditions simulating gastric environment affect the delivery of protein antigens from AFCo1 and this result could partially explain why i.n administration is more effective in vivo than i.g immunisation.


REFERENCES

  1. Pérez O, Bracho G, Lastre M, Sierra G, Campa C, Mora N, et al., inventors. Method of obtaining cochlear structures, vaccine compositions, adjuvants and intermediates thereof. WIPO, WO/ 2004/047805. Granted by Cuban Office for Intellectual Property OCPI23313. 2008.

  2. Pérez O, Bracho G, Lastre M, Mora N, del Campo J, Gil D, et al. Novel adjuvant based on a proteoliposome-derived cochleate structure containing native lipopolysaccharide as a pathogenassociated molecular pattern. Immunol Cell Biol 2004; 82(6):603-10.

  3. del Campo J, Zayas C, Romeu B, Acevedo R, González E, Bracho G, et al. Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses. Methods 2009;49:301–8.

  4. Sunesen VH, Pedersen BL, Kristensen HG, Mullertz A. In vivo-in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media. Eur J Pharm Sci 2005;24:305–13.

  5. Dressman JB, Reppas C. In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs. Eur J Pharm Sci 2000;11:S73–S80.

  6. Ranade VV, Hollinger MA. Drug Delivery Systems. 2nd ed. Florida, Boca Raton: CRC Press, Inc; 2004.

  7. Glomme A, Marz J, Dressman JB. Comparison of a Miniaturized Shake-Flask Solubility Method with Automated Potentiometric Acid/Base Titrations and Calculated Solubilities. J Pharm Sci 2005;94(1)1–16.

  8. Wang W, Qu X, Gray AI, Tetley L, Uchegbu IF. Self-Assembly of Cetyl Linear Polyethylenimine To Give Micelles, Vesicles and Dense Nanoparticles. Macromolecules 2004;37:9114–22.

  9. USP 29/NF 24, The United State Pharmacopeia/The National Formulary, United States Pharmacopeia Convention Inc., Rockville, USA: USP; 2006.

  10. Stippler E, Kopp S, Dressman JB. Comparison of US Pharmacopeia simulated intestinal fluid TS (without pancreatin) and phosphate standard buffer pH 6.8, TS of the International Pharmacopoeia with respect to their use in in vitro dissolution testing. Dissolution Technologies 2004;11(2):6-10.

  11. Chadwick S, Kriegel C, Amiji M. Delivery strategies to enhance mucosal vaccination. Expert Opin Biol Ther 2009; 9(4):427-40.

  12. Kawai T, Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. International Immunology 2009;21(4):317–37.

  13. Dieli F. Dendritic cells and the handling of antigen. Clin Exp Immunol 2003;134(2):178–80.

  14. Brandtzaeg P. Mucosal Immunity: Induction, Dissemination, and Effector Functions. Scandinavian Journal of Immunology 2009;70:505–15.

  15. Miclea RD, Varma PR, Peng A, Balu-Iyer SV. Development and characterization of lipidic cochleate containing recombinant factor VIII. Biochim Biophys Acta 2007;1768:2890–8.

  16. Nurit J, Margerit J, Terol A, Boudeville P. pH-metric study of the setting reaction of monocalcium phosphate monohydrate/calcium oxide-based cements. J Mater Sci Mater Med 2002;13:1007-14.

  17. Acevedo R, Callicó A, del Campo J, González E, Cedré B, González L, et al. Intranasal administration of proteoliposomederived cochleates from Vibrio cholerae O1 induce mucosal and systemic immune responses in mice. Methods 2009;49:309–15.




2020     |     www.medigraphic.com